Control Bionics Limited (ASX:CBL)
Australia · Delayed Price · Currency is AUD 0.0590
-0.0010 (-1.67%)
At close: Feb 5, 2026
Control Bionics Market Cap
Control Bionics has a market cap or net worth of 23.81 million as of February 5, 2026. Its market cap has increased by 50.26% in one year.
Market Cap
23.81M
Enterprise Value
23.57M
Revenue
6.14M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.06
Market Cap Chart
Since December 7, 2020, Control Bionics's market cap has decreased from 98.33M to 23.81M, a decrease of -75.79%. That is a compound annual growth rate of -24.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 23.81M | -3.28% |
| Dec 31, 2025 | 24.61M | 62.80% |
| Dec 31, 2024 | 15.12M | 126.88% |
| Dec 29, 2023 | 6.66M | -55.36% |
| Dec 30, 2022 | 14.93M | -59.58% |
| Dec 30, 2021 | 36.94M | -52.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 7, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Micro-X | 65.35M |
| CleanSpace Holdings | 52.52M |
| Nova Eye Medical | 48.42M |
| HeraMED | 45.89M |
| ImpediMed | 40.77M |
| CurveBeam AI | 36.03M |
| Atomo Diagnostics | 33.22M |
| CONNEQT Health | 26.94M |